Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Evaluation of RAD001 With Docetaxel and Bevacizumab in Patients With Metastatic Androgen Independent Prostate Cancer

NCT00574769 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00574769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00574769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Evaluation of RAD001 With Docetaxel and Bevacizumab in Patients With Metastatic Androgen Independent Prostate Cancer
Lead sponsor
University of Southern California
Phase
Phase 1/2
Overall status
Completed
Start date
February 17, 2010
Completion date
February 17, 2017
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer